https://www.selleckchem.com/pr....oducts/irak4-in-4.ht
33-0.96, P=0.034) over 181-365 days, with similar reductions present from 0-180 days. In those with heart failure with preserved ejection fraction, mortality trended lower with 2-3 drug classes (HR 0.43, 95% CI 0.18-1.02, P=0.054) and was significantly reduced with 4 drugs (HR 0.32, 95%CI 0.12-0.84, P=0.021) during 0-180 day follow-up. In heart failure with reduced ejection fraction, all-cause mortality was reduced during both 0-180 and 181-365 days when discharged on 2-3 (HR 0.30 for 181-365 days, 95%CI 0.14-0.64, P=0.002) or all 4
إعجاب
علق
شارك
